BioLineRx Ltd. Current Assets
BioLineRx Ltd. (BLRX) had Current Assets of $23.68 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-03-23
- 2025-12-31: Current Assets $23.68M.
- 2025-06-30: Current Assets $31.86M.
- 2024-12-31: Current Assets $27.10M.
- 2024-06-30: Current Assets $49.11M.
| Period end | Current Assets |
|---|---|
| 2025-12-31 | $23.68M 20-F · filed 2026-03-23 |
| 2025-06-30 | $31.86M 6-K · filed 2025-08-14 |
| 2024-12-31 | $27.10M 20-F · filed 2026-03-23 |
| 2024-06-30 | $49.11M 6-K · filed 2024-08-15 |
| 2023-12-31 | $47.18M 20-F · filed 2025-03-31 |
| 2023-06-30 | $34.69M 6-K · filed 2023-08-30 |
| 2022-12-31 | $52.00M 20-F · filed 2024-03-26 |
| 2022-06-30 | $44.10M 6-K · filed 2022-08-16 |
| 2021-12-31 | $57.40M 20-F · filed 2023-03-22 |
| 2021-06-30 | $67.07M 6-K · filed 2021-08-18 |
| 2020-12-31 | $22.88M 20-F · filed 2022-03-16 |
| 2020-06-30 | $28.17M 6-K · filed 2020-08-06 |
| 2019-12-31 | $28.21M 20-F · filed 2021-02-23 |
| 2019-06-30 | $36.21M 6-K · filed 2019-08-06 |
| 2018-12-31 | $31.98M 20-F · filed 2020-03-12 |
| 2018-06-30 | $42.80M 6-K · filed 2018-08-13 |
| 2017-12-31 | $50.38M 20-F · filed 2019-03-28 |
| 2016-12-31 | $36.10M 20-F · filed 2018-03-06 |